Commentary: Axillary Surgery, PM2.5, and Treatment With Tucatinib in Breast Cancer, November 2023October 27, 2023Breast Cancer
Induction chemotherapy in first line improves survival for locally advanced cervical cancerOctober 26, 2023
FDA OKs ivosidenib for IDH1-mutated myelodysplastic syndromesOctober 25, 2023Myelodysplastic Syndrome
Enfortumab vedotin/pembrolizumab hailed as new standard for upfront mUCOctober 25, 2023Genitourinary Cancer
Specialized care may curb suicide risk in veterans with disabilitiesOctober 25, 2023DepressionMental Health
